These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36315131)

  • 1. Pulmonary MRA During Pregnancy: Early Experience With Ferumoxytol.
    Starekova J; Nagle SK; Schiebler ML; Reeder SB; Meduri VN
    J Magn Reson Imaging; 2023 Jun; 57(6):1815-1818. PubMed ID: 36315131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gadolinium-enhanced and ferumoxytol-enhanced conventional and UTE-MRA for the depiction of the pulmonary vasculature.
    Knobloch G; Colgan T; Schiebler ML; Johnson KM; Li G; Schubert T; Reeder SB; Nagle SK
    Magn Reson Med; 2019 Nov; 82(5):1660-1670. PubMed ID: 31228293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia.
    Lai LM; Cheng JY; Alley MT; Zhang T; Lustig M; Vasanawala SS
    J Magn Reson Imaging; 2017 May; 45(5):1407-1418. PubMed ID: 27678106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
    Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
    J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of actionable findings on contrast enhanced magnetic resonance angiography ordered for pulmonary embolism evaluation.
    Schiebler ML; Ahuja J; Repplinger MD; François CJ; Vigen KK; Grist TM; Hamedani AG; Reeder SB; Nagle SK
    Eur J Radiol; 2016 Aug; 85(8):1383-9. PubMed ID: 27423676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
    Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
    Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferumoxytol-enhanced magnetic resonance angiography is a feasible method for the clinical evaluation of lower extremity arterial disease.
    Walker JP; Nosova E; Sigovan M; Rapp J; Grenon MS; Owens CD; Gasper WJ; Saloner DA
    Ann Vasc Surg; 2015 Jan; 29(1):63-8. PubMed ID: 25269682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
    Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
    J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.
    Li W; Tutton S; Vu AT; Pierchala L; Li BS; Lewis JM; Prasad PV; Edelman RR
    J Magn Reson Imaging; 2005 Jan; 21(1):46-52. PubMed ID: 15611942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
    Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
    Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year.
    Schiebler ML; Nagle SK; François CJ; Repplinger MD; Hamedani AG; Vigen KK; Yarlagadda R; Grist TM; Reeder SB
    J Magn Reson Imaging; 2013 Oct; 38(4):914-25. PubMed ID: 23553735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRA as the Preferred Test for Pulmonary Embolism During the Iodinated Contrast Media Shortage of 2022: A Single-Center Experience.
    Starekova J; Chu SY; Bluemke DA; Grist TM; Kusmirek JE; Nagle SK; Schiebler ML; Lubner MG; Nagpal P; Reeder SB
    AJR Am J Roentgenol; 2023 Dec; 221(6):736-746. PubMed ID: 37341181
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular Imaging With Ferumoxytol as a Contrast Agent.
    Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
    AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR Angiography of Pulmonary Vasculature.
    Bergmann LL; Ackman JB; Starekova J; Moeller A; Reeder S; Nagle SK; Schiebler ML
    Magn Reson Imaging Clin N Am; 2023 Aug; 31(3):475-491. PubMed ID: 37414473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of three-dimensional magnetic resonance angiography-fluoroscopy image fusion technique in guiding complex endovascular aortic procedures in patients with renal insufficiency.
    Schwein A; Chinnadurai P; Shah DJ; Lumsden AB; Bechara CF; Bismuth J
    J Vasc Surg; 2017 May; 65(5):1440-1452. PubMed ID: 28017584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis.
    Fananapazir G; Bashir MR; Corwin MT; Lamba R; Vu CT; Troppmann C
    J Magn Reson Imaging; 2017 Mar; 45(3):779-785. PubMed ID: 27504713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of Noncontrast-Enhanced Radial Quiescent-Interval Slice-Selective (QISS) Magnetic Resonance Angiography for the Diagnosis of Acute Pulmonary Embolism Compared to Contrast-Enhanced Computed Tomography and Cartesian Balanced Steady-State Free Precession.
    Salehi Ravesh M; Tesch K; Lebenatus A; Koktzoglou I; Edelman RR; Eden M; Langguth P; Graessner J; Jansen O; Both M
    J Magn Reson Imaging; 2020 Nov; 52(5):1510-1524. PubMed ID: 32537799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
    Bashir MR; Jaffe TA; Brennan TV; Patel UD; Ellis MJ
    Transplantation; 2013 Jul; 96(1):91-6. PubMed ID: 23680931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions.
    Benson DG; Schiebler ML; Repplinger MD; François CJ; Grist TM; Reeder SB; Nagle SK
    Br J Radiol; 2017 Jun; 90(1074):20160901. PubMed ID: 28306332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.